Wed, April 6, 2022

Yaron Werber Downgraded (BLUE) to Hold on, Apr 6th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ber-downgraded-blue-to-hold-on-apr-6th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Yaron Werber of Cowen & Co., Downgraded "bluebird bio, Inc." (BLUE) to Hold on, Apr 6th, 2022.

Yaron has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Yaron's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Yanan Zhu of "Wells Fargo" Maintained at Hold with Decreased Target to $8 on, Tuesday, March 8th, 2022


These are the ratings of the 2 analyists that currently disagree with Yaron


  • Gena Wang of "Barclays" Downgraded from Hold to Sell and Decreased Target to $4 on, Monday, March 7th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $5 on, Monday, March 7th, 2022